Tune In Tomorrow: SAM President & CEO Dr. Kevin Sabet will be on C-SPAN Washington Journal at 8 AM ET

Call in to join the discussion on May 2nd at 8 AM ET:

Democrats: (202) 748-8000

Independents: (202) 748-8002

Republicans: (202) 748-8001

Outside U.S. and Text: (202) 748-8003

Dr. Kevin Sabet in The Wall Street Journal: “While this thankfully won’t fully legalize marijuana, it is an alarming departure from both logic and science, tainted by election-year politics,” said Kevin Sabet, president and CEO of anti-pot group Smart Approaches to Marijuana. Read the rest of the piece in The Wall Street Journal.

Dr. Kevin Sabet in The New York Times: “Politics and industry influence have loomed over this decision from the very beginning,” said Mr. Sabet, now the president of the group, Smart Approaches to Marijuana, which focuses on aligning marijuana policy with scientific research. Read the rest of the piece in The New York Times.

Dr. Kevin Sabet in NBC News: "The only winner here is the marijuana industry, who will receive a new tax break and thus widen their profit margins," Sabet said. “Reclassifying marijuana as a Schedule III drug sends the message that marijuana is less addictive and dangerous now than ever before. In reality, today’s highly potent, super strength marijuana is more addictive and linked with psychosis and other mental illnesses, IQ loss and other problems.” Read the rest of the piece in NBC News.

Dr. Kevin Sabet in CBS News: "I think this decision reeks of electoral politics," said Kevin Sabet, president of Smart Approaches to Marijuana. "I definitely think this is an attempt to get young people to come out and vote." Read the rest of the piece in CBS News.

Dr. Kevin Sabet in Los Angeles Times: “Crude marijuana has never passed safety and efficacy protocols,” said Dr. Kevin Sabet, president of Smart Approaches to Marijuana, calling it a political decision in an election year. “Politics and industry influence have loomed over this decision from the very beginning.” Read the rest of the piece in Los Angeles Times.

Dr. Kevin Sabet in Reuters: “This industry, which has lobbied heavily to sell demonstrably harmful products, will now use this announcement to drive even more deliberate misinformation about these high-potency drugs to expand use and addiction," Kevin Sabet, the group's president, said in a statement. Read the rest of the piece in Reuters.

SAM mentioned in Politico: “A public comment period will follow the announcement of the DOJ’s decision on cannabis’ scheduling. Lawsuits challenging the move are also expected. Anti-legalization group Smart Approaches to Marijuana announced recently they would file a citizens’ petition to have the DOJ move cannabis back into schedule I if they do decide to move it out of that category.” Read the rest of the piece in Politico.

The fight is far from over.

Onward,

Dr. Kevin Sabet and the SAM/FDPS Team